For subscribers
Implants, drugs account for recent rise in S’pore hospital bill sizes, study of insurance claims finds
Sign up now: Get ST's newsletters delivered to your inbox
Singapore remains among countries in the Asia-Pacific with a lower 2025 projection for medical inflation than the regional average, the study found.
PHOTO: ST FILE
Follow topic:
SINGAPORE – A recent analysis of the drivers of healthcare inflation in Singapore found that a specific component that covers implants and drugs, and that makes up the bulk of total hospital bills, has ballooned.
Classified as “other fees”, this category typically also includes lab tests, ward procedure charges, costs of prescriptions and daily treatments.
